Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001946043-22-000003

Options or other derivatives

  • Chief Commercial Officer acquired 3,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirkov Kirko Chief Commercial Officer 2022-09-06 Grant or award · Options +3,000,000 $0.04 $105,000 3,000,000 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…